ABSTRACT Pseudohypoparathyroidism, type I (PHP-I) is an inherited disorder ofprimary resistance to multiple hormones that work by stimulating adenylate cyclase. In an attempt to clarify the mode of inheritance of PHP-I, we measured the activity of the N protein, a receptor-cyclase coupling component, in erythrocyte membranes. Erythrocyte N-protein activity was reduced by =50% in erythrocytes of 15 PHP-I patients and was normal in 19 oftheir clinically normal first degree relatives. Reduced N-protein activity and the PHP-I phenotype in these families exhibited both dominant and recessive patterns ofinheritance. This Two recent reports (10, 11) have described a biochemical defect in erythrocytes of PHP-I patients: partially deficient activity of a membrane protein, termed N, that is required for functional coupling of hormone receptors and catalytic adenylate cyclase. Generalized N-protein deficiency in endocrine target organs of PHP-I patients is an attractive hypothesis to explain the pathogenesis of the disease.
ABSTRACT Pseudohypoparathyroidism, type I (PHP-I) is an inherited disorder ofprimary resistance to multiple hormones that work by stimulating adenylate cyclase. In an attempt to clarify the mode of inheritance of PHP-I, we measured the activity of the N protein, a receptor-cyclase coupling component, in erythrocyte membranes. Erythrocyte N-protein activity was reduced by =50% in erythrocytes of 15 PHP-I patients and was normal in 19 oftheir clinically normal first degree relatives. Reduced N-protein activity and the PHP-I phenotype in these families exhibited both dominant and recessive patterns ofinheritance. This suggests that at least two distinct genetic loci are involved in inheritance of Nprotein deficiency. In two additional families, dominant inheritance ofthe PHP-I phenotype was associated with normal activities oferythrocyte N protein. Thus, it appears that mutation of at least one additional genetic locus, not involving the N protein, can produce PHP-I.
Pseudohypoparathyroidism, type I (PHP-I), is an inherited disease characterized by resistance to the metabolic effects ofparathyroid hormone (PTH) (1, 2) and other hormones (3) (4) (5) (6) that act by stimulating adenylate cyclase. Reported pedigrees offamilies that have PHP-I have suggested X-linked dominant (7) , autosomal dominant (8) , and recessive (9) inheritance ofthe disease. A reliable biochemical marker, closely related to the pathogenesis of PHP-I, should help to clarify this confusing picture.
Two recent reports (10, 11) have described a biochemical defect in erythrocytes of PHP-I patients: partially deficient activity of a membrane protein, termed N, that is required for functional coupling of hormone receptors and catalytic adenylate cyclase. Generalized N-protein deficiency in endocrine target organs of PHP-I patients is an attractive hypothesis to explain the pathogenesis of the disease.
We have used erythrocyte N-protein activity as a biochemical marker to investigate the inheritance ofPHP-I. The results suggest that erythrocyte N-protein deficiency and the clinical disease can be inherited by either dominant or recessive transmission. In addition, we report studies of two families in which clinically evident PHP-I is associated with quantitatively and qualitatively normal erythrocyte N-protein activities. These findings demonstrate the biochemical and genetic heterogeneity of PHP-I and suggest that mutations of at least three genetic loci can produce the disease.
METHODS
Informed Consent. Blood was drawn by venipuncture with the informed consent of both the patients and the normal volunteer subjects. Consent was obtained by procedures approved by Committees on Human Research of the University of California, San Francisco; the Sepulveda Veterans Administration Medical Center; the University of California, Los Angeles; and the Massachusetts General Hospital.
Assays of Erythrocyte N Protein. We assessed N-protein activity in erythrocyte ghosts by two assays, exactly as described (10) . In the first assay, we measured the ability of detergentsoluble extracts oferythrocyte ghosts to complement the N-protein deficiency of cyc-S49 mouse lymphoma membranes in vitro by using 100 tLM isoproterenol and 100 tLM guanosine-5'-0-(3-thiotriphosphate) (GTPyS) to stimulate adenylate cyclase, exactly as described (10) . In the second assay, we measured the cholera toxin-catalyzed transfer of [32P]ADP-ribose from [32P]NAD to the 42,000-dalton peptide subunit of N protein in erythrocyte membranes. Results for both assays are expressed as a percentage of the activity of a standard erythrocyte membrane preparation formed by pooling membranes from erythrocytes of normal subjects (10) .
In some experiments, we assessed N-protein activity in the complementation assay with other stimulators of adenylate cyclase, including 100 ,uM GTP (with or without isoproterenol), 10 ,uM prostaglandin E1 (PGE1), and 10 mM NaF. We used either of two detergents: 0.2% Lubrol 12A9, as described (10), or 0.5% sodium cholate/1.0 M NaCl. With the second detergent, reconstitution ofcyc-membranes was performed by using a modification of the method described by Sternweis and Gilman (12) . In this procedure, 0.5-1.0 M NaCl was present throughout the extraction and reconstitution procedure. Adenylate cyclase activity in reconstituted cyc-membranes was linear with increasing amounts of active cholate extract if it was supplemented with decreasing amounts ofa cholate extract that had been heated at 90°C for 10 min to destroy N-protein activity. The total amount of active and inactive cholate extract was always 40% of the total volume. RESULTS We will first describe findings in PHP-I patients whose erythrocytes showed reduced N-protein activities and then in a family in whom no erythrocyte defect was found.
PHP-I with Reduced Erythrocyte N-Protein. These 10 patients (Table 1) 'To whom reprint requests should be addressed.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. tures of PHP-I-short stature and brachydactyly (all 10); hypocalcemia requiring vitamin D therapy (9 of 10); decreased urinary excretion ofcyclic AMP (cAMP) in response to infusion of PTH (all of6 tested); elevated serum PTH (5 of8 tested). One patient (G-17, Table 1 ), a man whose resistance to PTH was described in the report by Albright et al. (1), subsequently underwent parathyroidectomy; his serum PTH now is low, and he continues to require treatment with vitamin D. Five patients required thyroid hormone replacement therapy for hypothyroidism.
By both the in vitro complementation and cholera toxin-catalyzed radiolabeling assays, N-protein activity was substantially reduced in erythrocytes of these 10 patients (filled circles, tients exhibited 57 ± 9% (mean ± SD) of the standard activity, as compared with 105 ± 12% in 16 normal subjects (P << 0.001). In the radiolabeling assay, erythrocytes of PHP-I patients showed 55 ± 9% of standard activity, compared with normal values of 110 ± 24% (P << 0.001).
One of these patients J-22, see Table 1 ) fits the description (13) of "pseudo-PHP." The mother of a daughter who has classical PHP-I, this patient had a round face, striking brachydactyly of fingers and toes, and short stature, but no history of hypocalcemia. g In spite ofher apparently normal endocrine status, this patient exhibited reduced erythrocyte N-protein activity by both the complementation and radiolabeling assays (42% and 41% of standard, respectively).
We studied erythrocytes of 19 clinically normal first degree relatives of eight patients (all except patients K-23 and L-24). In every case, clinically normal relatives had normal erythrocyte N-protein activities (96 ± 11% ofstandard for 19 samples tested in the complementation assay; 102 ± 19% of standard for 14 samples tested in the radiolabeling assay; these means are not statistically different from those of the normal subjects tested). Thus, reduced erythrocyte N-protein activity correlated perfectly with clinical appearance ofthe PHP-I phenotype in these families.
Pedigrees of the I and J families (Fig. 2) suggest contrasting modes of inheritance of both the PHP phenotype and erythrocyte N-protein deficiency. In the J family, the pattern is consistent with inheritance of a dominant phenotype, first appearing in the mother (patient J-22) described above. In the I family, two siblings have PHP-I and erythrocyte N-protein deficiency, although both parents are normal both clinically and by measurements of erythrocyte N protein. This pattern is consistent with inheritance of a recessive defect, as noted in a previous report of the I family (9) . In that report, incorrect paternity of the affected children was shown to be exceedingly unlikely, on the basis of testing for a variety of genetic markers, including blood groups, HL-A antigens, serum proteins, and erythrocyte enzymes. Consanguinity in this family was denied, and the parents came from diverse geographic and ethnic backgrounds (9) .
PHP-I with Normal Erythrocyte N Protein. Patients in another family who had classical PHP-I had normal erythrocyte N-protein activities, by both assays used ( (14) . We therefore asked whether N protein from erythrocytes ofpatients in the E and F families is partially "uncoupled" with respect to its ability to mediate stimulation of cAMP synthesis by hormones in the complementation assay.
The results of several experiments ( Under the same conditions, decay of N-protein activity from erythrocytes of 10 "low N" PHP-I patients and six "normal N" PHP-I patients (from families E and F) was similar to that of relative to that seen with NaF as the effector. All stimulators of adenylate cyclase were used at 100 ,uM, except PGE1 (10 jLM) and NaF (10 mM).
Iso, isoproterenol.
normal controls. Thus, we found no evidence of altered thermolability of N protein in any of the PHP-I patients. h DISCUSSION We have found decreased N-protein activity in erythrocytes of 15 PHP-I patients and normal N-protein activity in erythrocytes of 19 phenotypically normal first degree relatives of PHP-I patients in six affected families. The close correlation between the biochemical marker and the clinical disease strongly supports the hypothesis (10) that the primary biochemical lesion in some PHP-I patients is a generalized deficiency in the activity of the N protein, an essential component of hormone-sensitive adenylate cyclase in all animal cells (15) .i
Identification ofa primary biochemical defect in an inherited disease often reveals genetic and biochemical heterogeneity underlying the surface phenotype. Thus, we have studied two families with PHP-I in whom erythrocyte N-protein activities are normal [families E (10) and F (see Table 2 (10) ], and N-protein activity was normal in hypoparathyroid controls (10) . Similarly, excess serum PTH is neither necessary (patient G-17) nor sufficient [families E (10) and F] for expression of erythrocyte N-protein deficiency.
These patients could have inherited mutations that involve the catalytic unit of adenylate cyclase or that result in increased cAMP phosphodiesterase,j or they could have N-protein lesions not detected by our assays. We ruled out one subclass of such defects, functional uncoupling of N protein from hormone receptors (see Table 3 ).
The contrasting "dominant" and "recessive" pedigrees of the J and I families (see Fig. 2 ) strongly imply biochemical heterogeneity in the mechanisms that result in reduced N-protein activity. The N protein is composed of at least two dissimilar peptide subunits, whose stoichiometry is not yet defined (17) . A mutant allele producing an inactive version of one of these N peptides could explain dominant transmission of N-protein deficiency. Thus, affected heterozygotes would have -50% of normal N-protein activity (and presumably normal N-protein molecules) in their cells, as is the case in erythrocytes of two families that have apparently dominant inheritance of PHP-I (family J and patients A-1 and A-2 in ref. 10) . Most published pedigrees show apparently dominant transmission of PHP-I (7).
In contrast, the PHP-I syndrome and erythrocyte N-protein deficiency appear to have been recessively inherited in family I (see Fig. 2 ). How could mutant genes produce a normal clinical phenotype and normal erythrocyte N-protein activity in the parents but combine to produce both N-protein deficiency and PHP-I in their progeny? At present, speculation must be limited by our ignorance of the number and stoichiometry of peptide gene products represented in the N protein. It seems possible that products oftwo mutant genes might complement each other in a negative fashion in the progeny (e.g., by producing an inactive oligomeric N protein), while the presence of either
We have recently isolated a mutant S49 mouse lymphoma clone that provides a precedent for this possibility: In this clone, resistance to the cAMP-elevating effects of hormones and cholera toxin is associated with a 4-fold increase in cAMP phosphodiesterase activity, while adenylate cyclase and N-protein activities are normal (16) . mutant allele alone in the parents need not produce an inactive protein. This notion is akin to the "metabolic interference" hypothesis proposed by Johnson (18) to explain inheritance of PHP-I.
In any case, it is likely that the mechanism of inheritance in the I family is different from that we proposed for dominant inheritance and that it may affect a second genetic locus. This conclusion should be qualified: Because dominant disorders are not always completely expressed, it is possible that either parent in the I family could have the PHP-I genotype, although it is not expressed clinically or in measurements of erythrocyte Nprotein activity. In addition, none of our results unequivocally rule out X-linked transmission of PHP-I. If the disorder were X linked in the I family, the mother could carry the defective gene but not express it clinically or in her erythrocytes, owing to relative underrepresentation of active X chromosomes bearing the defective gene in-erythrocyte precursors and hormonally responsive tissues. Finally, the I family pedigree is also consistent with dominant inheritance ofa mutation in the germ cells of one of the parents, a possibility that cannot be ruled out.
In summary, the results of this study support the conclusion that deficiency of N-protein activity underlies the pathophysiology of many PHP-I patients and suggest that the PHP-I syndrome is genetically heterogeneous. It is likely that PHP-I can be produced by mutations of at least three genetic loci, two of which may affect N-protein activity. Biochemical dissection of this heterogeneity-as in the syndromes ofandrogen resistance (19)-may help to elucidate poorly understood or unsuspected biochemical mechanisms that are essential for normal endocrine regulation.
